Compile Data Set for Download or QSAR
maximum 50k data
Found 1952 of ic50 for UniProtKB: Q16853
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561951(6-[(Z)-2-(aminomethyl)-3-fluoro-allyloxy]-2-phenyl...)
Affinity DataIC50:  0.0400nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561952(6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-2-(pyrim...)
Affinity DataIC50:  0.0900nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561958(US11396495, No. 13 | ethyl 2-[6-[(Z)-2-(aminomethy...)
Affinity DataIC50:  0.110nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561957(US11396495, No. 12 | ethyl 2-[6-[(E)-2-(aminomethy...)
Affinity DataIC50:  0.140nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581410(US11505532, Compound WX079)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581415(US11505532, Compound WX085)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581433(US11505532, Compound WX103)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497223(US11001563, Compound WX126)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497185(US11001563, Compound WX079)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497190(US11001563, Compound WX085)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497208(US11001563, Compound WX103)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581448(US11505532, Compound WX126)
Affinity DataIC50:  0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561959(6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-2-(tetra...)
Affinity DataIC50:  0.220nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561955(6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-2-(tetra...)
Affinity DataIC50:  0.220nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581379(US11505532, Compound WX021)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497209(US11001563, Compound WX104)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581382(US11505532, Compound WX024)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581384(US11505532, Compound WX026)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581386(US11505532, Compound WX033)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581397(US11505532, Compound WX049)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581413(US11505532, Compound WX082)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581417(US11505532, Compound WX087)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581423(US11505532, Compound WX093)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581424(US11505532, Compound WX094)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581434(US11505532, Compound WX104)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497154(US11001563, Compound WX021)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497155(US11001563, Compound WX022)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497157(US11001563, Compound WX024)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497159(US11001563, Compound WX026)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497161(US11001563, Compound WX033)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497172(US11001563, Compound WX049)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497188(US11001563, Compound WX082)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497192(US11001563, Compound WX087)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497198(US11001563, Compound WX093)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497199(US11001563, Compound WX094)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581380(US11505532, Compound WX022)
Affinity DataIC50:  0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561953(6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-2-methyl...)
Affinity DataIC50:  0.320nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561950(6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-2-phenyl...)
Affinity DataIC50:  0.370nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581373(US11505532, Compound WX008)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497214(US11001563, Compound WX111)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581399(US11505532, Compound WX054)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581414(US11505532, Compound WX083)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581418(US11505532, Compound WX088)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581431(US11505532, Compound WX101)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581432(US11505532, Compound WX102)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM581439(US11505532, Compound WX111)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497148(US11001563, Compound WX008)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497156(US11001563, Compound WX023)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497174(US11001563, Compound WX054)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMembrane primary amine oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM497189(US11001563, Compound WX083)
Affinity DataIC50:  0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex® Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1952 total ) | Next | Last >>
Jump to: